神經(jīng)型一氧化氮合酶(NOS1)重組蛋白
Recombinant Nitric Oxide Synthase 1, Neuronal (NOS1)
NOS; nNOS; IHPS1; NC-NOS; N-NOS; bNOS; Neuronal NOS; Constitutive NOS; NOS type I; Nitric Ocide Synthase; Peptidyl-cysteine S-nitrosylase NOS1
- 編號RPA815Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜
- 預測分子量21.9kDa
- 實際分子量22kDa(差異分析請參閱說明書)
- 片段與標簽Glu53~Pro247 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點5.9
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1085 ¥ 2712 ¥ 5424 ¥ 16272 ¥ 40680
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute?in?10mM?PBS?(pH7.4)?to?a?concentration?of?0.1-1.0?mg/mL.?Do?not?vortex
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA815Mu01 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu04 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu02 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA815Mu03 | 神經(jīng)型一氧化氮合酶(NOS1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA815Mu01 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu02 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu03 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA815Mu04 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA815Mu71 | 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide [PubMed: 23359814] |
| J Endocrinol Invest.? | The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders [Pubmed:25245337] |
| Достижения фундаментальной, клинической медицины и фармации: материалы 72-й науч. сес. сотр. ун-та, 25-26 янв | Состояние эндотелиально-сосудистого фактора у беременных с артериальной гипертензией [handle:123] |
| Clinical Oral Investigations | Clinical antibacterial effectiveness and biocompatibility of gaseous ozone after incomplete caries removal [Pubmed:29858659] |
| Journal of Young Pharmacists | Antioxydant and Endotheliotropic Properties 4-Hydroxy-3, 5-Di-Tret-Butyl Cinnamic Acid under Conditions of Experimental Brain Ischemia [:] |
| The?Eurasian?Journal of Medicine | Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats [Doi: 10.5152/eurasianjmed.2018.18160] |
| Oxid Med Cell Longev | The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of Trichophyton rubrum Growth by HaCaT Cells [Pubmed: 32104540] |
| Archives of Oral Biology | Mandibular lateral deviation induces alteration in vascular endothelial growth factor expression and oxidative stress/nitric oxide generation in rat condyle, synovial?… [Pubmed: 31734543] |
| Dovepress | Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total?… [Pubmed: 32884241] |
| Clinical Oral Investigations | Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients [Pubmed:35426000] |
留言咨詢
